Dr. Xiao

	Department of Pathology
	Brigham and Women's Hospital
	A teaching Affliate of Harvard Medical School
Home About Us Services Research Education Staff For Patient For Medical Professional Alumni Anatomic Pathology Clinical Laboratories Blood Bank Cytogenetics About Our Research CMOP Histopathology Core Virtual Specimen Locator Biospecimen banking Vascular Research Division DGAP Project Center for Uterine Fibroids Residency AP Program CP program Fellowships CME Faculty Residents and Fellows Administration Patient Resources Referral Information Useful Links Referral Information Calendar and Events Education and Training Sign Out Forms Surg Path Manual Powerpath instructions Useful Links

Name and Present Position:

SHENG XIAO, Co-director, Solid Tumor Cytogenetics

Address:

Brigham and Women's Hospital, Department of Pathology, 75 Francis Street, Boston, MA 02115

Medical School (including school name, date and degree awarded):

1984 M.D. Suzhou Medical College, China
1989 M.S. Harbin Medical College (Medical Genetics), China

Graduate Medical Education:

1984 Intern in Medicine, Suzhou People's Hospital, Jisun, China
1984-86 Resident in Surgery, Ning Xiang 716 Hospital, Hunan, China
1986-87 Research Fellow in Medical Genetics, Harbin Medical College, Harbin, China
1987-89 Clinical Fellow in Medical Genetics, Harbin Medical College
1993-96 Research Fellow in Pathology, Brigham and Women's Hospital

Certification:

1984 National Board of Medicine (China)
1999 American Board of Medical Genetics: Clinical Cytogenetics
2001 Active candidate of the American Board of Medical Genetics: Clinical Molecular Genetics

Current Academic Appointment:

Assistant Professor of Pathology, Harvard Medical School, Boston, MA

Current Medical Staff Appointment:

Co-director, Solid Tumor Cytogenetics, Brigham and Women's Hospital

Selected Bibliography:

Xiao S, Li D, Vijg J, Corson JM, Sugarbaker DS, Fletcher JA. Codeletion of p15 and p16 in primary malignant mesothelioma. Oncogene 1995; 11:511-515.
Xiao S, Renshaw A, Cibas ES, Hudson TJ, Fletcher JA. Novel fluorescence in situ hybridization approaches in solid tumors: Characterization of frozen specimens, touch preparations, and cytologic preparations. Am J Pathol 1995; 147:896-904.
Xiao S, Li D, Corson JM, Vijg J, Fletcher JA. Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma. Cancer Res 1995; 55:2968-2971.
Xiao S, Lux ML, Reeves R, Hudson TJ, Fletcher JA. HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage cells from pulmonary harmartoma. Am J Pathol 1997; 150:901-910.
Xiao S, Nalabolu SR, Aster JC, Ma J, Abruzzo L, Jaffe ES, Stone R, Weissman SM, Hudson TJ, Fletcher JA. FGFR1 fused with a novel zinc finger gene, ZNF-198, in the t(8;13) lymphoma syndrome. Nat Genet 1998; 18:84-87.
Xiao S, McCarthy MG, Aster J, Fletcher JA. ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain. Blood 2000; 96:699-704.